Last update 24 May 2025

HS-236

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
HS236
Target
FGFR4
Action
antagonists
Mechanism
FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists)
Therapeutic Areas
Neoplasms
Active Indication
Advanced Malignant Solid Neoplasm
Inactive Indication-
Originator Organization
Zhejiang Hisun Pharmaceutical Co., Ltd.Zhejiang Hisun Pharmaceutical Co., Ltd.
Active Organization
Zhejiang Hisun Pharmaceutical Co., Ltd.Zhejiang Hisun Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with HS-236
CTR20223083
/ CompletedPhase 1
HS236胶囊在中国健康受试者中的食物影响研究
[Translation] Food effect study of HS236 capsules in Chinese healthy subjects
CTR20201674
/ RecruitingPhase 1
评价FGFR4小分子共价抑制剂HS236胶囊在晚期实体瘤患者的安全性、耐受性、药代动力学及药效学特征的剂量递增、开放的Ⅰ期临床试验
[Translation] A dose-escalation, open-label phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HS236 capsule, a small molecule covalent inhibitor of FGFR4, in patients with advanced solid tumors
100 Clinical Results associated with HS-236
Login to view more data
100 Translational Medicine associated with HS-236
Login to view more data
100 Patents (Medical) associated with HS-236
Login to view more data
100 Deals associated with HS-236
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Zhejiang Hisun Pharmaceutical Co., Ltd.Zhejiang Hisun Pharmaceutical Co., Ltd.
21 Sep 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free